Stanford, California 94305

  • Blood and Marrow Transplant (BMT)


Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.

Study summary:

To use high dose chemotherapy with autologous stem cell rescue to try to increase the chance of long term control and cure of the disease.


Inclusion Criteria:- must be in remission - adequate organ function Exclusion Criteria:- prior MDS - active infection - liver disease



Primary Contact:

Principal Investigator
Laura Johnston
Stanford University

Backup Contact:


Location Contact:

Stanford, California 94305
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 30, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.